Enteric Disease Testing Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     Global Enteric Disease 
Testing Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  to  the  la tes t  repor t  by  IMARC Group,  t i t l ed  "Enter ic  Disease 
Test ing  Market :  G lobal  Industry  Trends,  Share ,  S ize ,  Growth ,  
Opportuni ty  and Forecast  2024-2032,"  the  g loba l  en te r ic  d isease tes t ing  
marke t  s ize  reached US$ 4 .2  B i l l ion  in  2023.
Report Enter ic  d iseases a re  caused by the  ingest ion  o f  food  or  wate r  contaminated 
by  m ic rob ia l  tox ins  and  mic roorgan isms.  These  microorgan isms en te r  
Highlight and th rough the  mouth by  coming in  con tac t  w i th  an in fec ted  person 's  feces  o r  w i th  an imals  and the i r  env i ronments ,  a t tack ing the gas t ro in tes t ina l  t rac t .  
Ente r ic  d iseases can cause  symptoms l i ke  d ia r rhea ,  nausea,  vomi t ing ,  fever ,  
Description ch i l l s ,  abdomina l  c ramps,  and a  loss  o f  appet i te .  In  recen t  years ,  the  
approva l  fo r  the  commerc ia l i za t ion  o f  nove l  techno log ies  and  the  launch  o f  
new produc ts  have revo lu t ion ized  en ter ic  d isease tes t ing .
Request  for  a  PDF sample  of  th is  report :  
ht tps : / /www. imarcgroup.com/ente r ic -d isease- tes t ing-marke t / requestsample
Report Description
G l ob a l  En t e r i c  D i s ease  Tes t i ng  M ar ke t  T rend s :
The  i n c r eas ing  ca ses  o f  en t e r i c  d i sease s ,  su ch  as  cho le r a ,  am eb ias i s ,  Cam py lob ac t e r i os i s  an d  Hepa t i t i s  A ,  r e p r es en t  t h e  
p r im ar y  f a c t o r  t ha t  pos i t i ve l y  im p ac t s  t he  g loba l  e n t e r i c  d i sea se  t es t i ng  m a r ke t .  T h i s  can  b e  a t t r i b u t ed  t o  t he  un hy g ien ic  
cond i t i ons ,  uns a f e  d r i n k ing  wa t e r  an d  p oo r  san i t a t i on .  Be s ides  t h i s ,  w i t h  t he  r ec en t  ou t b r eak  o f  co r o nav i r u s  d i seas e  
( CO V I D- 19 ) ,  t es t i ng  f o r  en t e r i c  d i sease s  ha s  i nc r eas ed  as  t he  v i r us  i s  v a r i ab l y  f ou nd  i n  hum an  e n t e r i c  sam p les  du r i n g  t h e  
cou r se  o f  i n f ec t i on .  As  a  r esu l t ,  m any  h ea l t hc a r e  c en t e r s  a r e  u nde r t ak in g  r esea r ch  t o  d i sco ve r  t h e  co - r e la t i on  be t wee n  
en t e r i c  d i s ease  and  CO VI D- 19 .  
Fu r t h e r m o r e ,  as  i nd i v idua l s  a r e  be com in g  m or e  a war e  o f  t h e  be ne f i t s  o f  ea r l y  d iagno s i s ,  t hey  a r e  i nc r e as ing l y  op t i ng  f o r  
t he  t es t i ng  o f  e n t e r i c  d is eas es .  T he  l ead in g  he a l t h ca r e  com pan ies  a r e  i nve s t i n g  i n  r esea r ch  an d  dev e lop m en t  ( R&D )  
ac t i v i t i es  t o  adva nce  t h e  en t e r i c  d i seas e  t es t i ng  t e chno lo g ies  t o  i nc r ease  t he  e f f i c i en cy  o f  d iagno s i s .  So m e o f  t h e  o t he r  
f ac t o r s ,  such  as  im p r ov i ng  he a l t hca r e  i n f r as t r uc t u r e ,  va r i ou s  t e chno lo g i ca l  advan cem en t s  a nd  t he  em er g ing  t r end  o f  
m ed ic a l  t o u r i sm ,  a r e  exp ec t e d  t o  c r e a t e  a  pos i t i ve  o u t l ook  f o r  t he  m ar ke t .
Look i ng  f o rw ard ,  t he  mark e t  i s  exp ec t ed  t o  g row  a t  a  CA G R o f  3 . 1 % d ur i ng  202 4 - 203 2 .
V i ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / e nt e r i c - d i s ease - t es t i ng - mark e t
Breakup by Product Type:
• Reagents and Consumables
• Equipment
 
Breakup by Technique:
• Molecular Diagnost ics
Report • Immunodiagnost ics
Segmentation
Breakup by Disease Type:
• Bacter ial  Enter ic Disease
o C. Diffi ci le
o Campylobacter iosis
o Cholera
o E. Col i
o H. Pylor i
o Salmonel losis
o Shigel losis
• Viral  Enteric Disease
o Rotavirus
o Norovirus
o Others
Report 
• Parasit ic Enteric Disease
Segmentation o Amebiasis
o Cryptosporid iosis
o Giardiasis
Breakup by End User:
• Hospital  Diagnost ic Laboratories
• Independent Diagnostic Laboratories
• Academic and Research Insti tutes
• Others
Breakup by Region:
Report • North America
• Asia-Pacifi c
Segmentation
• Europe
• Latin America
• Middle East and Afr ica
• Abbott Laboratories
• BD (Becton, Dickinson and Company)
• Bio-Rad Laboratories Inc.
• Biomerica Inc.
Competitive 
• Biomérieux SA
Landscape • Cepheid Inc. (Danaher Corporation)
with Key • Coris BioConcept
• DiaSorin
Players
• Meridian Bioscience Inc.
• Quest Diagnost ics.
How has the global enteric disease testing market performed 
so far and how will it perform in the coming years?
What are the key regional markets?
Key What has been the impact of COVID-19 on the global enteric 
disease testing market?
Questions 
Answered in What is the breakup of the market based on the product type?
the Report
What is the breakup of the market based on the technique?
What is the breakup of the market based on the disease 
type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the 
industry?
What are the key driving factors and challenges in the 
industry?
Key What is the structure of the global enteric disease testing 
market and who are the key players?
Questions 
Answered in What is the degree of competition in the industry?
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  E n t e r i c  D i s e a s e  T e s t i n g  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t  T y p e
    6 . 1     R e a g e n t s  a n d  C o n s u m a b l e s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     E q u i p m e n t
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  T e c h n i q u e
    7 . 1     M o l e c u l a r  D i a g n o s t i c s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
     7 . 2     I m m u n o d i a g n o s t i c s
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  D i s e a s e  T y p e
    8 . 1     B a c t e r i a l  E n t e r i c  D i s e a s e
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a j o r  T y p e s
           8 . 1 . 2 . 1  C .  D i f f i c i l e
           8 . 1 . 2 . 2  C a m p y l o b a c t e r i o s i s
           8 . 1 . 2 . 3  C h o l e r a
           8 . 1 . 2 . 4  E .  C o l i
Table of            8 . 1 . 2 . 5  H .  P y l o r i           8 . 1 . 2 . 6  S a l m o n e l l o s i s
           8 . 1 . 2 . 7  S h i g e l l o s i s
        8 . 1 . 3  M a r k e t  F o r e c a s t
Contents     8 . 2     V i r a l  E n t e r i c  D i s e a s e
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a j o r  T y p e s
           8 . 2 . 2 . 1  R o t a v i r u s
           8 . 2 . 2 . 2  N o r o v i r u s
           8 . 2 . 2 . 3  O t h e r s
        8 . 2 . 3  M a r k e t  F o r e c a s t
    8 . 3     P a r a s i t i c  E n t e r i c  D i s e a s e
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a j o r  T y p e s
           8 . 3 . 2 . 1  A m e b i a s i s
           8 . 3 . 2 . 2  C r y p t o s p o r i d i o s i s
           8 . 3 . 2 . 3  G i a r d i a s i s
        8 . 3 . 3  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /e nte r i c -d i s ea se - te s t i ng -m a rke t / t
o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: